A duniya ibuprofen API kasuwa ya zarce dalar Amurka miliyan 572.9 a cikin 2019 kuma an saita shi don ingantaccen hangen nesa na ci gaba a cikin 2019 - 2029, kamar yadda binciken sabon Binciken Kasuwa na Gaba (FMI). Abubuwan farko don haษaka kasuwar Ibuprofen API sun haษa da ci gaba da buฦatun magunguna marasa tsada marasa tsada (NSAID), da sikelin da shekarun wuraren masana'antu.
Haษaka ฦarancin magunguna na API da kuma haษa ฦarfin aiki don shawo kan waษannan matsalolin, bullar masana'antun magunguna masu tsada a cikin ฦasashe daban-daban da samar da magungunan API, musamman a cikin ฦasashe masu tasowa, suna ฦara haษaka haษakar kasuwar ibuprofen API.
Don ฦarin fahimtar kasuwa, nemi samfurin wannan [email kariya] https://www.futuremarketinsights.com/reports/sample/rep-gb-11260
Masana'antar API ta Pharmaceutical tana ganin raguwar samarwa da buฦatar Ibuprofen API, dakatar da samarwa daga manyan masana'antun API na ibuprofen, rugujewar sarkar samar da kayayyaki a china wanda hakan ke haifar da raguwar siyarwa a Indiya. Rashin daidaituwa a cikin Ibuprofen API shine saboda dalilai kamar ฦananan adadin masu fafatawa, rage yawan amfani da, ฦananan matakin gefe, sabon damar mafi girma a cikin hadaddun hadaddun da API mai girma, saurin binciken kayan aiki ta FDA, da haษaka ฦarfin samarwa. na ta hanyar haษaka da haษakawa.
FMI tana Nazartar Tasirin COVID-19 akan Kasuwa
Binciken FMI ya nuna cewa cutar ta COVID-19 mai ci gaba tana yin illa ga ci gaban kasuwa. Wuhan, China ita ce cibiyar samar da API. Yankin shine farkon barkewar cutar sankara, saboda haka, ya dakatar da masana'antarsa โโna ษan lokaci. Bugu da ari, kasar Sin ita ce fitacciyar ko mai samar da APIs da suka hada da, penicillin da erythromycin, a duniya. Masu masana'antu da masu rarrabawa a cikin ฦasar suna zargin shingen kayan aiki da ฦarancin ma'aikata sakamakon cutar ta COVID-19 don jinkirin samarwa da sufuri.
Mabuษin Takeaway na Nazarin Kasuwar API na Ibuprofen
- Babban mayar da hankali kan kawar da matsin lamba na sarkar samar da kayayyaki saboda gibin bukatu ana magance shi ta hanyar haษaka ฦarfin samarwa, haษaka haษakawa shine mahimman dabarun da aka tsara don saduwa da buฦatu a cikin sarari na Ibuprofen API.
- Yawancin magungunan kashe kumburi ana kera su ne a Asiya, musamman a China da Indiya. Kusan 80% na jimillar API ษin anti-inflammatory ana kera su a Indiya da China kuma yawancin API ษin da aka kera a waษannan ฦasashe ana fitar da su zuwa wasu yankuna da suka ci gaba - Arewacin Amurka da Turai.
- Babban farashin gaba da ฦananan matakin gefe a cikin Ibuprofen API sun haifar da hauhawar farashin 20-30% a cikin ฦirar ฦwayoyi na ฦarshe da ฦananan tallace-tallace a cikin shekarar da ta gabata.
- Kasuwancin Ibuprofen API yana haษaka cikin yanayi, tare da manyan masana'antun da ke riฦe da kusan 90% na ฦimar kasuwa kamar 90%. Don haka, haษaka sha'awar CMOs da manyan masana'antun API ana tsammanin haษaka ฦimar ฦimar kasuwar ibuprofen API.
- Ma'amala mai girma ta ฦungiyoyin Masana'antu na Kwangila idan aka kwatanta da kamfanonin harhada magunguna kuma a tsakanin ฦarfin samarwa da fa'idar farashi sama da kamfanonin harhada magunguna ana sa ran za su samar da manyan aljihu na kudaden shiga.
- Fadada tafkin maras lafiya da ke cinye magungunan da ba a sarrafa su kamar yadda OTC kuma ke da alhakin haษakar amfani da ibuprofen API na cikin gida a Kudu da Gabashin Asiya.
Don mahimman bayanai kan wannan kasuwa, nemi ฦwararren a nan @ https://www.futuremarketinsights.com/askus/rep-gb-11260
ฦananan farashin aiki, wadatar albarkatun ฦasa da ake buฦata don ibuprofen API suna daga cikin mahimman abubuwan da ke haifar da haษakar kasuwar ibuprofen API a Kudancin Asiya. Bugu da kari, ingantacciyar tallafi na tsari don kafa kasuwancin masana'antu na ibuprofen API, ฦananan manufofin haraji suna haษaka haษakar Gabas da Kudancin Asiya kasuwar ibuprofen API.
ฦarfin ฦarfi, da Dabarun Haษe-haษe & Saye don Faษaษa Gabatar Yanki
Manyan 'yan wasa a kasuwannin API na ibuprofen - SI Group, Inc., BASF SE, Hubei Biocause Pharmaceutical Co., Ltd. (BIOCAUSE Inc.), IOL Chemicals, Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd., da Solara Active Pharma Sciences Limited - suna mai da hankali kan faษaษa kasuwanci ta hanyar haษaka, haษin gwiwar haษin gwiwa, yarjejeniyar rarrabawa da kuma ษaukar yuwuwar da ba a iya amfani da shi na kasuwar Ibuprofen API.
- A cikin 2018, IOL Chemicals, babban masana'anta na Ibuprofen API na Indiya, ya faษaษa ฦarfin samarwa zuwa 12000 MT daga ฦarfin da ya gabata na 7500 MT. Tare da haษaka ฦarfin, IOL Chemicals yana cike gibin samar da buฦatu wanda ke tashi saboda tsayayyen tsarin gyarawa a China. Wannan yunฦurin na iya ฦara amfanar masana'antun Indiya waษanda ke neman ฦarfafa ฦafarsu a kasuwar Ibuprofen API.
- Sayen da Solara Active Pharma Sciences Limited ya samu a cikin 2018 na Ibuprofen API kadarorin Strides and Sequent ya baiwa kamfanin damar kama babban fayil na sassan niche na kasuwar Ibuprofen API.
- Haษin gwiwar tsakanin Granules India Ltd (GIL) da Hubei Biocause Heilen Pharmaceutical Co. Ltd. suna da wurin samarwa a Jingmen, China. A cikin tattaunawar kwanan nan, Granules India Ltd (GIL) na shirin ficewa daga kasuwancin haษin gwiwa.
Bugu da ฦari, abubuwan da aka samu na yanzu suna mai da hankali kan haษaka iya aiki, da ฦarfin masana'anta na ฦดan wasan Ibuprofen API na yanzu don samun gasa da haษaka haษakar kudaden shiga a cikin yanayin kasuwa.
ฦarin Hazaka masu Fa'ida akan Kasuwar APIprofen
Hasashen Kasuwa na gaba yana kawo cikakken rahoton bincike game da hasashen haษakar kudaden shiga a duniya, yanki, da matakan ฦasa kuma yana ba da nazarin sabbin hanyoyin masana'antu a cikin kowane yanki daga 2014 zuwa 2029. Kasuwancin Ibuprofen API na duniya ya kasu kashi daki-daki don rufewa. kowane bangare na kasuwa da kuma gabatar da cikakken tsarin basirar kasuwa ga mai karatu. Binciken yana ba da haske mai gamsarwa akan kasuwar Ibuprofen API bisa tushen mai amfani na ฦarshe (Kungiyar Masana'antar Kwangila da Kamfanonin Magunguna), a cikin manyan yankuna bakwai.
Tuntube Mu
Naรบrar No: 1602-006
Jumeirah Bay 2
Makirci A'a: Saukewa: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
LinkedIn| Twitter| blogs
